Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference Call on August 9, 2024
Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference Call on August 9, 2024
Following the live call, a replay will be available on the Company's website, , under "Investor Info."BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended June 30, 2024, after the close of the financial markets on Thursday, August 8, 2024.
美國紐交所上市公司Xtant Medical Holdings, Inc. (NYSE American: XTNT)是一家全球醫療科技公司，專注於外科治療脊柱疾病的解決方案。今天宣佈，該公司將在2024年8月8日週四收盤後發佈截至2024年6月30日第二季度的財務業績。
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Friday, August 9, 2024, at 9:00 AM ET to review results.
總裁兼首席執行官Sean Browne和首席財務官Scott Neils將會在2024年8月9日星期五上午9:00（美國東部時間）主持電話會議，回顧業績。
Conference Details:
Conference Date: Friday, August 9, 2024
Conference Time: 9:00 AM ET
Conference dial-in: 888-999-3182
International dial-in: 848-280-6330
Passcode: Xtant Medical Holdings
Conference Call Name: Xtant Medical Q2 2024 Financial Results
Webcast Link:
會議詳情：
美國東部時間（ET）12:30-12:55。
主持人：
羅傑·宋，MD、CFA，生物技術股票研究分析師
諾瓦瓦克斯醫藥參與者：
約翰·C·雅各布斯，總裁兼首席執行官
會議
投資者會議
記錄
錄像對話的重播將在公司網站的活動和演示頁面上提供，網址爲
會議日期：2024年8月9日
會議時間：美國東部時間上午9:00
電話會議撥入號碼：888-999-3182
國際撥入號碼：848-280-6330
會議密碼：Xtant Medical Holdings
電話會議名稱：Xtant Medical Q2 2024財務業績報告
網絡廣播鏈接：
Following the live call, a replay will be available on the Company's website, , under "Investor Info."
電話會議結束後，重播將會在公司網站「投資者資訊」下提供。
About Xtant Medical Holdings, Inc.
關於Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. () is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
Xtant Medical的使命是珍視捐贈的禮物，讓我們的患者能夠儘可能地生活得更加充實和完整，這也是我們公司的推動力。Xtant Medical Holdings, Inc.是一家全球醫療科技公司，專注於設計、開發和商業化全面的生物製品和脊柱植入系統組合，以促進複雜脊柱、畸形和退行性手術中的脊柱融合。Xtant公司致力於爲客戶服務，以最高的誠信經營，員工敬業才華橫溢。
The symbols and denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
符號和表示xtant醫療控股及其附屬公司的商標和註冊商標分別在美國和其他國家/地區註冊。本新聞稿中提到的所有其他商標和商業名稱均歸其各自所有者所有。
Investor Relations Contact
投資者關係聯繫人
Brett Maas • Managing Partner, Hayden IR
brett@haydenir.com • (646) 536-7331
佈雷特·馬斯（Brett Maas）·哈倫IR（Hayden IR）執行合夥人
brett@haydenir.com ·（646）536-7331
SOURCE: Xtant Medical Holdings, Inc.
來源：xtant medical holdings，inc。
譯文內容由第三人軟體翻譯。
